Literature DB >> 23060308

The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study.

Sansin Tuzun1, Nurten Eskiyurt, Ulku Akarirmak, Merih Saridogan, Helena Johansson, Eugene McCloskey, John A Kanis.   

Abstract

INTRODUCTION: With the development of country-specific FRAX® tools to estimate fracture probability, guidance is required on the fracture probability at which treatment can be recommended.
OBJECTIVES: The aim of the present study was to determine FRAX-based intervention thresholds in men and women from Turkey and determine their population impact. PATIENTS AND METHODS: Intervention thresholds for treatment and assessment thresholds for measuring BMD were devised using the strategy adopted by the National Osteoporosis Guideline Group of the UK but applied to the fracture probabilities in Turkey. The number of men and women potentially eligible for treatment was determined from the distribution of FRAX-based probabilities of a major fracture (Turkish model, version 3.6) in a representative sample of 26,394 men and women aged 50 years or more.
RESULTS: Intervention thresholds, set at the probability equivalents of a woman with a prior fragility fracture rose with age from 7.0 % at the age of 50 years to 31 % at the age of 90 years. Approximately 8.6 % of the female Turkish population aged 50 years or more had a prior fragility fracture and would be eligible for treatment. A further 13.6 % without a prior fracture would be eligible for treatment. In contrast, the number of men aged 50 years or more eligible for treatment was 3.1 %.
CONCLUSIONS: FRAX-based guidelines can be developed and are expected to avoid unnecessary treatment of individuals at low fracture risk and direct treatments to those at high risk. The adoption of FRAX-based intervention thresholds will demand a reappraisal of the criteria for reimbursement of interventions and health economic assessment.

Entities:  

Mesh:

Year:  2012        PMID: 23060308     DOI: 10.1007/s11657-012-0101-4

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  7 in total

1.  Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis.

Authors:  A-J Chang; Q Ying; X-N Chen; W-M Wang; N Chen
Journal:  Osteoporos Int       Date:  2016-07-08       Impact factor: 4.507

2.  Evaluation of pain, quality of life, and patient satisfaction in parenterally treated patients with postmenopausal osteoporosis.

Authors:  Tuğba Özsoy-Ünübol; Gülseren Akyüz; Samaya Mirzayeva; Tuba Güler
Journal:  Turk J Phys Med Rehabil       Date:  2020-02-26

3.  Agreement between FRAX scores calculated with and without bone mineral density in women with osteopenia in Turkey.

Authors:  Nese Olmez Sarikaya; Secil Kapar Yavasi; Gulten Tan; Servet Satiroglu; Arife Hilal Yildiz; Bengi Oz; Ozlem Yoleri; Asuman Memis
Journal:  Clin Rheumatol       Date:  2014-01-29       Impact factor: 2.980

Review 4.  A brief history of FRAX.

Authors:  John A Kanis; Helena Johansson; Nicholas C Harvey; Eugene V McCloskey
Journal:  Arch Osteoporos       Date:  2018-10-31       Impact factor: 2.617

5.  FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK.

Authors:  E McCloskey; J A Kanis; H Johansson; N Harvey; A Odén; A Cooper; C Cooper; R M Francis; D M Reid; D Marsh; P Selby; F Thompson; S Hewitt; J Compston
Journal:  Osteoporos Int       Date:  2015-06-16       Impact factor: 4.507

6.  Agreement between the Turkey Guidelines and the Fracture Risk Assessment Tool®-based Intervention Threshold.

Authors:  Ahmet Imerci; Nevres Hurriyet Aydogan; Kursad Tosun
Journal:  J Bone Metab       Date:  2018-05-31

7.  Evaluation of the effects of β1-selective beta-blockers on bone mineral density and fracture risk in postmenopausal women

Authors:  Betül Yavuz Keleş; Meltem Vural; Burcu Önder; Kadriye Öneş
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.